Markets News

As part of the reciprocal tariffs announcement, US President Donald Trump imposed 34 per cent duties on Chinese goods. Faced with the tariffs, China retaliated with a similar degree of tariffs on US goods, setting off a potential trade war, and dampening investors' sentiment for the time being.

Congress slams PM Modi over massive market crash, blames tariff moves and likens his economic policies to Donald Trump’s.

After Trump's tariff terror, the stock market crashed on April 7th, leaving investors disheartened. However, amidst this decline, there are some PSU stocks that can quietly make you rich. Their fundamentals are strong.

Trump's tariff fears have so gripped the market that on April 7, the stock market crashed by more than 3000 points. The Nifty also fell by more than 900 points. During this period, Siemens' stock fell by more than 45%. Let's find out the top falling stocks.

Bitcoin fell as much as 7% to $77,077 during early morning trading in Singapore, according to Bloomberg. Ethereum, the second-largest digital currency, plunged to $1,538—marking its lowest intra-day level since October 2023.

Indian stock markets plunged sharply on April 7, wiping out ₹16 lakh crore in investor wealth, in one of the biggest single-day crashes, echoing past financial crises.

Indian stock markets on Monday (April 7) witnessed a massive crash as Sensex plunged over 3,200 points and Nifty50 fell below 21,900. Here are the top 5 reasons behind today's bloodbath, including Trump tariffs, global sell-off, recession fears, and commodity slump.

Federal Reserve Chair Jerome Powell signaled patience on rate cuts amid rising uncertainty, while U.S. President Donald Trump framed the current moment as an opportunity to lower borrowing costs and sustain economic momentum.

According to Dow Jones Market Data, a record $5 trillion has been wiped from markets over the past two days since President Donald Trump announced sweeping reciprocal tariffs.

H.C. Wainwright told investors in a research note that the clinical hold on key Elevidys trials in Europe heightens the uncertainty around the future of the franchise.